Current evidence suggests different PD-L1 expressions in rare pancreatic cancer histologies, with a higher expression detected in squamous cell carcinoma, potentially predicting a better response to immunotherapy than PDAC. Here, CD274 is linked to familial pancreatic carcinoma.